Actively Recruiting
Study to Test a New Crosslinking Hyaluronan Hydrogel for Preventing Adhesions After Anterior Talofibular Ligament Repair Surgery and Improving Ankle Movement
Led by Talent Cro Inc. · Updated on 2025-02-14
50
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of a new crosslinking hyaluronan hydrogel in preventing adhesions after anterior talofibular ligament ATFL repair surgery. The study focuses on patients with ATFL injury who experience lateral ankle pain and have a history of recurrent ankle sprains. The goal is to see if applying this hydrogel improves ankle range of motion compared to conventional therapy without antiadhesion products. Participants are randomly assigned to receive either the DEFEHERE Absorbable Adhesion Barrier hydrogel or conventional therapy without any antiadhesion product. The hydrogel is delivered as a 1.0 mL syringe during surgery. The study is conducted as a prospective, single-center, randomized, double-blinded clinical trial. The main treatment phase includes monitoring over a period up to 70 days after surgery. During the study, participants will undergo various assessments including range of motion measurements, anterior talar translation tests, pain scales, and questionnaires assessing ankle instability and function. These evaluations occur at baseline and multiple points up to day 70 after surgery. Researchers will also collect patient satisfaction scores and monitor for any adverse effects. The total participation period includes follow-up visits over approximately 10 weeks.
CONDITIONS
Brief Title
To Evaluate the Effectiveness of the Use of a Novel Crosslinking Hyaluronan Hydrogel on the Prevention of the Adhesion Occurrence After Anterior Talofibular Ligament Repair Surgery
Research Team
Y
Yan-Yu Chen Doctor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here